Comparison of 2 doses of PEG-interferon alfa-2b plus weight based ribavirin for treatment of previously untreated patients with genotype 1 HCV infection

被引：0
|
作者：
Cox, PP [1 ]
Do, H [1 ]
Carithers, RL [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：342A / 342A
页数：1
相关论文
共 50 条
  • [21] High dose consensus interferon and ribavirin for treatment of chronic Hepatitis C infection in patients who are resistant to PEG-Interferon alfa-2b and ribavirin: Preliminary results
    Fernandez, AA
    Singh, S
    Victor, A
    Santiago, M
    Rothstein, KD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S93 - S94
  • [22] PEG-interferon after interferon alfa-2b for hypereosinophilic syndrome
    Butterfield, J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S222 - S222
  • [23] Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
    Tsugiko Oze
    Naoki Hiramatsu
    Changho Song
    Takayuki Yakushijin
    Sadaharu Iio
    Yoshinobu Doi
    Masahide Oshita
    Hideki Hagiwara
    Eiji Mita
    Toshifumi Ito
    Yoshiaki Inui
    Taizo Hijioka
    Shinji Tamura
    Harumasa Yoshihara
    Atsuo Inoue
    Yasuharu Imai
    Eijiro Hayashi
    Michio Kato
    Masanori Miyazaki
    Atsushi Hosui
    Takuya Miyagi
    Yuichi Yoshida
    Tomohide Tatsumi
    Shinichi Kiso
    Tatsuya Kanto
    Akinori Kasahara
    Norio Hayashi
    Tetsuo Takehara
    Journal of Gastroenterology, 2012, 47 : 334 - 342
  • [24] SVR AND ANEMIA IN HCV-GENOTYPE 1 PATIENTS TREATED WITH PEG-INTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV): LITTLE EFFECT OF RIBAVIRIN DOSAGE
    Boeker, Klaus
    Mauss, Stefan
    Zehnter, Elmar
    Schober, Andreas
    Moog, Gero
    Lutz, Thomas
    Schuchmann, Marcus
    Heyne, Renate
    Schiffelholz, Willi
    John, Christine
    Hey, Karl-Heinz
    Baumgarten, Axel
    Geyer, Peter R.
    Pape, Stefan
    Lohmeyer, Juergen
    Schmidt, Wolfgang
    Alshuth, Ulrich
    Hueppe, Dietrich
    HEPATOLOGY, 2010, 52 (04) : 768A - 769A
  • [25] Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
    Oze, Tsugiko
    Hiramatsu, Naoki
    Song, Changho
    Yakushijin, Takayuki
    Iio, Sadaharu
    Doi, Yoshinobu
    Oshita, Masahide
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Inui, Yoshiaki
    Hijioka, Taizo
    Tamura, Shinji
    Yoshihara, Harumasa
    Inoue, Atsuo
    Imai, Yasuharu
    Hayashi, Eijiro
    Kato, Michio
    Miyazaki, Masanori
    Hosui, Atsushi
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Hayashi, Norio
    Takehara, Tetsuo
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (03) : 334 - 342
  • [26] Treatment with Peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia
    Saadoun, D
    Cacoub, P
    JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 737 - 737
  • [27] Adherence to therapy enhances sustained response in chronic hepatitis C patients receiving peg-interferon alfa-2b plus ribavirin
    McHutchison, J
    Manns, M
    Harvey, J
    Albrecht, JK
    JOURNAL OF HEPATOLOGY, 2001, 34 : 2 - 3
  • [28] A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infection
    Suzuki, Fumitaka
    Toyota, Joji
    Ikeda, Kenji
    Chayama, Kazuaki
    Mochida, Satoshi
    Hayashi, Norio
    Ishikawa, Hiroki
    Miyagoshi, Hidetaka
    Hu, Wenhua
    McPhee, Fiona
    Hughes, Eric A.
    Kumada, Hiromitsu
    ANTIVIRAL THERAPY, 2014, 19 (05) : 491 - 499
  • [29] Thyroid Dysfunction Induced by Peginterferon alfa-2b (Peg-2b)/Ribavirin (RBV) is a Favorable Predictor of SVR in Patients with HCV Genotype 1, but not HCV Genotype 2/3 Infection
    Mauss, Stefan
    Hueppe, Dietrich
    Zehnter, Elmar
    Manns, Michael P.
    Teuber, Gerlinde
    Dahhan, Tarek
    Meyer, Ulrike
    Witthoeft, Thomas
    Moeller, Bernd
    Dikopoulos, Nektarios
    Brack, Jochen
    Stade, Barbara
    Bilzer, Manfred
    HEPATOLOGY, 2012, 56 : 567A - 567A
  • [30] Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL
    Lo Nigro, L
    La Spina, M
    Mirabile, E
    Pisana, P
    Schilirò, G
    Guardo, P
    PEDIATRIC BLOOD & CANCER, 2004, 43 (02) : 185 - 185
12345